Who backs Surv BioPharma?
15 investors| Investor | Type |
|---|---|
| Nippon Venture Capital | Venture capital |
| FFG Venture Business Partners | Other |
| Keio Innovation Initiative | Venture capital |
| Kyoto University Innovation Capital | Venture capital |
| Sagin Capital & Consulting | Venture capital |
| Tokai Tokyo Investment | Other |
| Fukuoka Jisho | Other |
| DCI Partners | — |
| Fujita Innovation Capital | — |
| Higin Capital | — |
| + 5 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Surv BioPharma
- ·The full record, as it builds
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 15 firms already write checks for companies like Surv BioPharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.